DeSantis Damon 4
4 · INTEGRATED BIOPHARMA INC · Filed Jul 19, 2023
Insider Transaction Report
Form 4
DeSantis Damon
Director
Transactions
- Award
Stock Option (right to buy)
2023-07-18+50,000→ 50,000 totalExp: 2033-07-18→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]The exercise price of each stock option will be the closing price of the Issuer's Common Stock on July 25, 2023, which represents the fifth trading day after the grant date.
- [F2]The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2023, December 31, 2023, March 31, 2024 and June 30, 2024.